The development of lifestyle modification for cardiovascular risk factors based on their related genotypes in a Japanese general population.
The development of lifestyle modification for cardiovascular risk factors based on their related genotypes in a Japanese general population.
批准号:
16590500
负责人:
OKAMURA Tomonori
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We examined the interaction between lifestyle and polymorphisms of salt-sensitive genes and the effect on hypertension in a Japanese population. Among 1,647 subjects not receiving antihypertensive medication, in a combined analysis of angiotensinogen (AGT) and adducin (ADD1) polymorphisms, double homozygosity of 235Thr or 460Trp was not associated with hypertension. A multiple logistic regression analysis showed that age, body mass index, alcohol consumption, family history of hypertension and combined AGT M235T Thr/Thr and ADD1 Trp/Trp polymorphisms were associated with hypertension. However, there was no interaction between eating salty food and combined AGT and ADD1 polymorphisms. Furthermore, eating salty food was not associated with hypertension in a multivariate analysis. Therefore, a combination of the AGT and ADD1 polymorphisms appears to have an association with hypertension. However, a simple questionnaire about salt intake was not sufficient to confirm the relation between salt intake and hypertension or salt-sensitive genes.Cholesteryl ester transfer protein (CETP) is a key enzyme in high-density lipoprotein (HDL) cholesterol metabolism. We also studied the association between CETP TaqIB polymorphism and the HDL cholesterol. The serum HDL cholesterol levels of female participants with the B2B2 genotype were significantly higher than those with other genotypes (p<0.001). Multiple regression analysis with covariates such as age, waist to hip (W/H) ratio, alcohol drinking, current smoking, non-HDL cholesterol, and logarithm of triglyceride revealed that the CETP TaqIB genotype was an independent determinant of HDL cholesterol levels. Subgroup analysis revealed that an interaction was observed between the CETP TaqIB polymorphism and alcohol consumption in the regulation of HDL cholesterol levels in men (p=0.049) and women (p=0.022).
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Epidemiologic aspects of ALDH2 genotypes and cardiovascular parameters. Comprehensive Handbook of Alcohol Related Pathology, Vol.2.(Preedy V and Watson R (eds).)
ALDH2 基因型和心血管参数的流行病学方面。
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Yamada M, Honda S, Iwanaga M, Kondo H, Mine M, Yokota K, Shibata Y., Okamura T.]
通讯作者:
Okamura T.
Combined analysis of polymorphisms in angiotensinogen and adducin genes and their effects on hypertension in a Japanese sample : The Shigaraki Study
日本样本中血管紧张素原和内收蛋白基因多态性的联合分析及其对高血压的影响:信乐研究
DOI:
--
发表时间:
2005
期刊:
Hypertension Research 28(8)
影响因子:
--
作者:
[Tamaki S, Okamura T, et al.]
通讯作者:
et al.
Preedy V and Watson R (eds). Epidemiologic aspects of ALDH2 genotypes and cardiovascular parameters. Comprehensive Handbook of Alcohol Related Pathloogy, Vol.2.
Preedy V 和 Watson R(编辑)。
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[Okamura T.]
通讯作者:
Okamura T.
Epidemiologic aspects of ALDH2 genotypesand cardiovascular parameters.
ALDH2 基因型和心血管参数的流行病学方面。
DOI:
--
发表时间:
2005
期刊:
Comprehensive Handbook of Alcohol Related Pathology (Preedy V and Watson R eds.) Vol.2
影响因子:
--
作者:
[Kurimori S, Fukuda Y, et al., 吉田 稔 他, Okamura T]
通讯作者:
Okamura T
The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample
基于人群的样本中高密度脂蛋白胆固醇水平与胆固醇酯转移蛋白 TaqIB 基因多态性之间的关联受到饮酒的影响
DOI:
--
发表时间:
2007
期刊:
Atherosclerosis 191(1)
影响因子:
--
作者:
[Tsujita Y, et al.]
通讯作者:
et al.
共 8 条
Assessment of quality of lipid parameters as a novel risk factor for cardiovascular diseases in community-based epidemiologic studies.
-
批准号:16H05249
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.57万
-
财政年份:2016
-
负责人:OKAMURA Tomonori
-
依托单位:
The effect of soluble form LOX-1 and LOX-1 ligands containing apolipoprotein B on subclinical atherosclerosis in community dwellers..
-
批准号:23390178
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.9万
-
财政年份:2011
-
负责人:OKAMURA Tomonori
-
依托单位:
The impact of plasma homocysteine and B complex vitamins on subclinical atherosclerosis amongst community-dwelling American and Japanese men
-
批准号:20590670
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:OKAMURA Tomonori
-
依托单位:
Determinants of serum cholesteryl ester transfer protein(CETP) and its association with coronary artery calcium in Japanese and US men.
-
批准号:18590595
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:OKAMURA Tomonori
-
依托单位:
Association of anti-oxidant vitamins and C-reactive protein with non-invasive brachial-ankle pulse wave velocity and ankle -brachial index in Japanese middle-aged male workers
-
批准号:13670360
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:2001
-
负责人:OKAMURA Tomonori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
番茄红素通过LXRα-CETP-ABCA1/G1信号通路抑制支架内新生动脉粥样硬化形成的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:侯经远
-
依托单位:
护心通络方通过干预CETP介导脂质代谢防治动脉粥样硬化的作用机制
-
批准号:2020JJ8025
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:王华
-
依托单位:
新型双位点CETP抑制剂的设计、合成及生物活性研究
-
批准号:81703367
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:袁浩亮
-
依托单位:
五环三萜类CETP抑制剂的设计、合成及活性评价
-
批准号:81602957
-
项目类别:青年科学基金项目
-
资助金额:17.3万元
-
批准年份:2016
-
负责人:陈冬寅
-
依托单位:
CETP靶点作用分子鹰嘴豆芽素A与肽CPe-III相互作用及协同调节脂代谢机制研究
-
批准号:31571825
-
项目类别:面上项目
-
资助金额:68.0万元
-
批准年份:2015
-
负责人:薛照辉
-
依托单位:
CETP输运胆固醇酯机理的分子动力学研究
-
批准号:11374237
-
项目类别:面上项目
-
资助金额:76.0万元
-
批准年份:2013
-
负责人:张胜利
-
依托单位:
促甲状腺激素对胆固醇酯转运蛋白(CETP)的影响及其机制
-
批准号:81270970
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2012
-
负责人:周新丽
-
依托单位:
利用体细胞基因打靶突变技术制作CETP基因敲除家兔模型研究
-
批准号:81070250
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:刘恩岐
-
依托单位:
脂肪细胞表达的CETP对脂肪细胞胆固醇代谢及膜脂质筏的影响
-
批准号:30771040
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2007
-
负责人:周红文
-
依托单位:
新型心血管药物研究-基于药效团设计合成CETP抑制剂
-
批准号:30672540
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐柏玲
-
依托单位: